Login

VC Firm investing in the lifesciences|Daniel Yadegar,Chief Medical Officer,Newpath Partners 00:10:00

Share On Facebook Share On Twitter

Daniel Yadegar is the Co-Founder and CMO of Newpath Management.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Hawkins Project Exploration Update: Key Findings and High-Grade Sampling Insights
00:10:00
Arlandastad Group's CEO, Dieter Sand, and CFO Henrik Morén discuss the past year and the future with Carnegie's Rikard Engberg|CEO , Arlandastad Group AB (publ)
00:10:00
"Matthias Taft, CEO of BayWa r.e., advocates for sustainability in a compelling interview, emphasizing its pivotal role in shaping a greener future."|Marcus Pöllinger is the Chief Executive Officer of BayWa AG
00:10:00
ROCA Industry’s Ionuț Bindea on the Future of Romania’s Building Materials Market | Ionuț Bindea, CEO, ROCA Industry Holdingrock1 SA.
00:10:00
Canada's Mining Innovation: Insights from MSTA CANADA at Colombia Gold Symposium 2021 | Ryan McEachern - MANAGING DIRECTOR of Mining Suppliers Trade Association CANADA
00:10:00
San Bartolomé Processing Plant and Growth Strategy
00:10:00
Endeavour Silver Corp: Advancing Low-Cost Tarren Era Project to Double Production and Enhance Financial Strength
00:10:00
"Exploring ESG and Responsible Investing: A Discussion with State Street Global Advisors' Brie Williams, Hosted by SoFi's Brian Walsh"
00:10:00
Robert LoCascio, CEO of LivePerson, revealed a business strategy secret during his Mobile World Congress interview.
00:10:00
Life and Health Firms Drive High M&A Activity in Specialty Distribution
00:10:00
Mastering the Advanced Financial Modeler (AFM) Accreditation: What You Need to Know | Ian Schnoor, Executive Director ,Financial Modeling Institute.
00:10:00
AdvTech Reports Strong Financial Performance with 22% Revenue Growth and Dividend Declaration | Roy Douglas, CEO, Advtech Ltd .

© 2026 Nehu